Catheter ablation for persistent atrial fibrillation: A multicenter randomized trial of pulmonary vein isolation (PVI) versus PVI with posterior left atrial wall isolation (PWI) - The CAPLA study
| Autor: | Bhupesh Pathik, Joseph B. Morton, Rajeev Kumar Pathak, M Ginks, Liang-Han Ling, Deep Chandh Raja, Sonia Azzopardi, Louise Segan, Laurence D. Sterns, Prashanthan Sanders, Sandeep Prabhu, Geoffrey Lee, Jonathan M. Kalman, Alex J.A. McLellan, A. Al-Kaisey, Hariharan Sugumar, Aleksandr Voskoboinik, David Chieng, Peter M. Kistler, Christopher M. Reid, Michael C.G. Wong, Sue Finch, Ramanathan Parameswaran |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
medicine.medical_specialty
Heart disease medicine.medical_treatment Catheter ablation Pulmonary vein law.invention Left atrial wall Randomized controlled trial Recurrence law Internal medicine Atrial Fibrillation Humans Medicine Prospective Studies business.industry Atrial fibrillation Ablation medicine.disease Clinical trial Treatment Outcome Pulmonary Veins Catheter Ablation Cardiology Cardiology and Cardiovascular Medicine business |
| Zdroj: | American Heart Journal. 243:210-220 |
| ISSN: | 0002-8703 |
| DOI: | 10.1016/j.ahj.2021.09.015 |
| Popis: | Background The success of pulmonary vein isolation (PVI) is reduced in persistent AF (PsAF) compared to paroxysmal AF. Adjunctive ablation strategies have failed to show consistent incremental benefit over PVI alone in randomized studies. The left atrial posterior wall is a potential source of non-PV triggers and atrial substrate which may promote the initiation and maintenance of PsAF. Adding posterior wall isolation (PWI) to PVI had shown conflicting outcomes, with earlier studies confounded by methodological limitations. Objectives To determine whether combining PWI with PVI significantly improves freedom from AF recurrence, compared to PVI alone, in patients with PsAF. Methods This is a multi-center, prospective, international randomized clinical trial. 338 patients with symptomatic PsAF refractory to anti-arrhythmic therapy (AAD) will be randomized to either PVI alone or PVI with PWI in a 1:1 ratio. PVI involves wide antral circumferential pulmonary vein (PV) isolation, utilizing contact force sensing ablation catheters. PWI involves the creation of a floor line connecting the inferior aspect of the PVs, and a roof line connecting the superior aspect of the PVs. Follow up is for a minimum of 12 months with rhythm monitoring via implantable cardiac device and/or loop monitor, or frequent intermittent monitoring with an ECG device. The primary outcome is freedom from any documented atrial arrhythmia of > 30 seconds off AAD at 12 months, after a single ablation procedure. Conclusions This randomized study aims to determine the success and safety of adjunctive PWI to PVI in patients with persistent AF. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect